Category: Events

Survey on Aimovig for CADTH – part 2

CADTH (Canadian Agency for Drugs and Technology in Health) is currently evaluating the clinical value of Aimovig (erenumab) for the prevention of migraine. The input from patient groups is solicited. If you have tried Aimovig for migraine prevention, we need your input! This survey is…

What causes migraine? Scientific answers.

People with migraine often wonder what’s the cause of their disabling symptoms. The science of migraine has been progressing, thanks to the hard work of researchers all around the world. Dr Elizabeth Leroux recently gave a talk in Calgary about the last discoveries on migraine….

Global Patient Advocacy Committee

GPAC = Global Patient Advocacy Committee People working together to improve migraine care and understanding. GPAC is a group of physicians, patient advocates and representants from institutions, associations and industries related to the migraine field. Countries represented included Brazil, Japan, Spain, Italy, France, US, UK,…